The World Health Organization’s Technical Advisory Group recommended on Wednesday that India’s coronavirus vaccine COVAXIN should be granted emergency use listing status.
The Indian first homegrown COVID-19 vaccine was developed by domestic company Bharat Biotech in collaboration with the country’s Council of Medical Research (ICMR) and the National Institute of Virology (NIV).
The two-dose vaccine has estimated to be 77.8% effective in preventing COVID-19 and 93.4% successful in preventing severe cases of coronavirus infection. The latest studies also determined the jab’s efficacy versus the Delta strain at 65.2%.
A 16-year-old student from the El Kawasim area of the Shorbane district of Mahdia governorate passed…
A cruise ship belonging to the French company Rivages du Monde, "World Explorer," docked today,…
The Municipality of Tunis reported that a demolition operation was carried out on Saturday, April…
A civil protection brigade was deployed Saturday to El Mazouna, in the Sidi Bouzid governorate,…
Lebanese President Joseph Aoun said on Sunday that Lebanon does not want war and that…
The death toll in the deadly shooting in central Nigeria's state of Benue has reportedly…
This website uses cookies.